Susan E. Quaggin

CIK: 0001997505

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)11 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABBV

AbbVie Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

ABBV
AbbVie Inc.
Sep 30, 2026
Award(A)
Stock Equivalent Units
Direct
59 shares at avg. $261.59-
ABBV
AbbVie Inc.
Jun 30, 2026
Award(A)
Stock Equivalent Units
Direct
62 shares at avg. $251.64-
ABBV
AbbVie Inc.
May 8, 2026
Award(A)
Direct
1.1K shares-
ABBV
AbbVie Inc.
Mar 31, 2026
Award(A)
Stock Equivalent Units
Direct
71 shares at avg. $217.49-
ABBV
AbbVie Inc.
Dec 31, 2025
Award(A)
Stock Equivalent Units
Direct
68 shares at avg. $228.49-
ABBV
AbbVie Inc.
Sep 30, 2025
Award(A)
Stock Equivalent Units
Direct
67 shares at avg. $231.54-
ABBV
AbbVie Inc.
Jun 30, 2025
Award(A)
Stock Equivalent Units
Direct
81 shares at avg. $185.62-
ABBV
AbbVie Inc.
May 9, 2025
Award(A)
Direct
1.2K shares-
ABBV
AbbVie Inc.
Mar 31, 2025
Award(A)
Stock Equivalent Units
Direct
71 shares at avg. $209.52-
ABBV
AbbVie Inc.
Dec 31, 2024
Award(A)
Stock Equivalent Units
Direct
84 shares at avg. $177.70-
ABBV
AbbVie Inc.
Sep 30, 2024
Award(A)
Stock Equivalent Units
Direct
75 shares at avg. $197.48-

		Type	Shares	Price		Ownership
Sep 30, 2026	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	59	$261.59	-	Direct
Jun 30, 2026	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	62	$251.64	-	Direct
May 8, 2026	ABBV AbbVie Inc.	Award(A)	1,118	-	$0	Direct
Mar 31, 2026	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	71	$217.49	-	Direct
Dec 31, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	68	$228.49	-	Direct
Sep 30, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	67	$231.54	-	Direct
Jun 30, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	81	$185.62	-	Direct
May 9, 2025	ABBV AbbVie Inc.	Award(A)	1,203	-	-	Direct
Mar 31, 2025	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	71	$209.52	-	Direct
Dec 31, 2024	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	84	$177.70	-	Direct
Sep 30, 2024	ABBV AbbVie Inc.	Award(A) Stock Equivalent Units	75	$197.48	-	Direct

1-11 of 11 transactions

About Quaggin Susan E

Quaggin Susan E (SEC CIK 0001997505) files insider reports with the SEC as Director of AbbVie Inc. (ABBV).

Signal8 holds 11 ownership filings by Quaggin Susan E, all Form 4s, filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 11 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Quaggin Susan E's filings is in NORTH CHICAGO, IL.

Recent filings by Quaggin Susan E

Sep 30, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
Jun 30, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
May 8, 2026: Grant or award of ABBV shares (Form 4, code A).
Mar 31, 2026: Grant or award of ABBV derivative securities (Form 4, code A).
Dec 31, 2025: Grant or award of ABBV derivative securities (Form 4, code A).

Other insiders filing for AbbVie Inc. (ABBV)

Carethers John, Director
RAPP EDWARD J, Director
Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER
FALK THOMAS J, Director
WADDELL FREDERICK H, Director
Roberts Rebecca B, Director

How to read Form 4 transaction codes